Professor Matthew Kiernan

the budget, all of those sort of things are sort of, they're markers that things are going okay.

The tests that we're talking about are more biomarkers following a clinical presentation.

So someone has been brought in either on their own volition or by a family member or a friend.

Like, you know, Matthew's not the same person that he seemed to be or there seems to be some minor, like high-level stuff.

And then we would go into this sort of cognitive assessment.

And then that cognitive assessment would suggest what we need to do.

Like it might say that actually, because part of it as well is assessment of anxiety and mood.

So I might score badly, but it might be like really, really down in my mood score.

Yeah.

And then if I can improve my mood score, does the cognitive process come out?

People use this word pseudo-dementia.

So in other words, it's not really dementia.

It's something else that's triggering the process.

We'd also then look at blood test results, vitamin levels, thyroid function.

These are all markers that will help brain function, and they could account for the presentation.

So this whole...

early dementia and you know diagnosed what is it 10 years or 15 years a minute and then and what how are they at the end of it well well the beauty is back to the autonomy issue people can have some control of the modifiable risk factor so let's say i was not scoring as well as i should be or i'd been measuring it over the last 10 years and i'm starting to drop off and

If I start to adjust some of my lifestyle factors and some of the blood results I've got, can I either plateau out or start to raise it again?

And these are things that, yes, we can do.

So when you say, oh, is it 10 years?